These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 35186107)

  • 1. Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Mild and Common-Type COVID-19: A Randomized, Controlled, Multicenter Clinical Study.
    Zhang L; Wu L; Xu X; Yuan Y; Jiang R; Yan X; Zhang X; Gao Y; Shang H; Lian B; Hu J; Mei J; Wu S; Liu Q
    Evid Based Complement Alternat Med; 2022; 2022():8733598. PubMed ID: 35186107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.
    Hu K; Guan WJ; Bi Y; Zhang W; Li L; Zhang B; Liu Q; Song Y; Li X; Duan Z; Zheng Q; Yang Z; Liang J; Han M; Ruan L; Wu C; Zhang Y; Jia ZH; Zhong NS
    Phytomedicine; 2021 May; 85():153242. PubMed ID: 33867046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study.
    Ma C; Chen B; Li Y; Gu L; Dong J; Xu Z; Wei L; He Z; Nie X; Feng S; Cao B; Sun L; Yang L; Li X; Jiang R
    Front Med (Lausanne); 2023; 10():1302219. PubMed ID: 38314028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Lianhua Qingwen Capsule in Treatment of Asymptomatic COVID-19 Patients: A Randomized, Controlled Multicenter Trial.
    Zhang L; Wu L; Xu X; Yuan Y; Jiang R; Yan X; Zhang X; Gao Y; Shang H; Hu J; Wang X; Mei J; Wu S; Liu Q
    J Integr Complement Med; 2022 Nov; 28(11):887-894. PubMed ID: 36342811
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study.
    Xu X; Zhang J; Zheng W; Yang Z; Zhao X; Wang C; Su H; Zhao L; Xue L; Hu F; Xu X; Wen M; Liao J; Zeng Z; Wang L; Zeng J; Guo Y; Li B; Liu Q
    Ann Palliat Med; 2021 May; 10(5):5146-5155. PubMed ID: 33894725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
    Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
    Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of traditional Chinese medicine (Maxingshigan-Weijing Decoction) on COVID-19: An open-label randomized controlled trial.
    Zeng C; Yuan Z; Zhu J; Wang Y; Xie Y; Ye R; Cheng J
    Integr Med Res; 2021; 10(Suppl):100782. PubMed ID: 34660195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial.
    Natarajan S; Anbarasi C; Sathiyarajeswaran P; Manickam P; Geetha S; Kathiravan R; Prathiba P; Pitchiahkumar M; Parthiban P; Kanakavalli K; Balaji P
    Trials; 2020 Oct; 21(1):892. PubMed ID: 33109252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of Baoji Tablets for treating common cold with summer-heat and dampness syndrome: study protocol for a randomized controlled trial.
    Feng RZ; Lv JQ; Johnson AK; Montoya JD; Mao B
    Trials; 2013 Dec; 14():440. PubMed ID: 24359521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Andrographolide drop-pill in treatment of acute upper respiratory tract infection with external wind-heat syndrome: a multicenter and randomized controlled trial].
    Chang J; Zhang RM; Zhang Y; Chen ZB; Zhang ZM; Xu Q; Yang YP; Long YY; Liu LL; Cai HY; Gao J; Lu N; Mao B; Wang L; Li TQ
    Zhong Xi Yi Jie He Xue Bao; 2008 Dec; 6(12):1238-45. PubMed ID: 19063836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
    Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen.
    Zhang SY; Fu JY; Guo XY; Wu DZ; Zhang T; Li C; Qiu L; Shao CR; Xiao HP; Chu NH; Deng QY; Zhang X; Yan XF; Wang ZL; Zhang ZJ; Jiang X; Zheng YJ; Zheng PY; Zhang HY; Lu ZH
    Infect Dis Poverty; 2020 May; 9(1):50. PubMed ID: 32381098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Study for Safety Evaluation of GXN Tablets Combined with Aspirin in Long-Term Treatment of Coronary Heart Disease.
    Zi M; Li R; Lu F; Li Q; Zhao Y; Jia H; Sun M; Yang Q; Qiu P; Wei E; Wang S; Li R; Zhang W; Cao W; Li Y; Xu H; Gao R
    Evid Based Complement Alternat Med; 2021; 2021():6658704. PubMed ID: 34211572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Safa O; Hassani-Azad M; Farashahinejad M; Davoodian P; Dadvand H; Hassanipour S; Fathalipour M
    Trials; 2020 Sep; 21(1):790. PubMed ID: 32933552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Randomized double-blind parallel controlled multicenter trial of Reyanning Mixture in treatment of acute tonsillitis].
    Lyu J; Yang C; Wang LX; Xie YM; Yu XQ; Gu L; Gao F; Zhang JX; Yu XK
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(14):3282-3291. PubMed ID: 32726041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.